Поисковый запрос: (<.>A=Holst, Jens Juul$<.>) |
Общее количество найденных документов : 35
Показаны документы с 1 по 20
|
|
1.
| An appetite-suppressing peptide, its compositions and use
|
2.
| An appetite-suppressing peptide, its compositions and use
|
3.
| Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual 'бета'-cell function // Diabetes Care, 2011. Vol. 34, N 7.-С.1463-1468
|
4.
| Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual 'бета'-cell function // Diabetes Care, 2011. Vol. 34, N 7.-С.1463-1468
|
5.
| The interstinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin // Dig. Diseases and Sci., 2010. Vol. 55, N 10.-С.2785-2796
|
6.
| The interstinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin // Dig. Diseases and Sci., 2010. Vol. 55, N 10.-С.2785-2796
|
7.
| Glucagon-like peptide-2 increases mesenteric blood flow in humans // Scand. J. Gastroenterol., 2009. Vol. 44, N 3.-С.314-319
|
8.
| Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes // Diabetes Care, 2001. Vol. 24, N 4.-С.720-725
|
9.
| Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes // Diabetes Care, 2001. Vol. 24, N 4.-С.720-725
|
10.
| Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men // Diabetes Care, 2001. Vol. 24, N 9.-С.1640-1645
|
11.
| GLP-1 slows solid gastric emptying and inhibits insulin glucagon, and PYY release in humans // Amer. J. Physiol., 1999. Vol. 277, N 3.-С.R910-R916
|
12.
| The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects // Clin. Endocrinol., 1998. Vol. 49, N 5.-С.569-572
|
13.
| The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects // Clin. Endocrinol., 1998. Vol. 49, N 5.-С.569-572
|
14.
| Wettergren Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow // Amer. J. Physiol., 1998. Vol. 275, N 5.-С.G984-G992
|
15.
| Holst Glukagonlignende peptid-1 // Ugeskr. Laeger, 1998. Vol. 160, N 16.-С.2371-2377
|
16.
| Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion // Diabetes, 1998. Vol. 47, N 1.-С.45-49
|
17.
| Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic 'бета'-cells by both proximal and distal regulatory steps in stimulus-secretion coupling // Diabetes, 1998. Vol. 47, N 1.-С.57-65
|
18.
| Holst Glukagonlignende peptid-1 // Ugeskr. Laeger, 1998. Vol. 160, N 16.-С.2371-2377
|
19.
| Holst Glukagonlignende peptid-1 // Ugeskr. Laeger, 1998. Vol. 160, N 16.-С.2371-2377
|
20.
| Holst Glukagonlignende peptid-1 // Ugeskr. Laeger, 1998. Vol. 160, N 16.-С.2371-2377
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"